Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Anna-Karin Falck"'
Autor:
Carina Forsare, Martin Bak, Anna-Karin Falck, Dorthe Grabau, Fredrika Killander, Per Malmström, Lisa Rydén, Olle Stål, Marie Sundqvist, Pär-Ola Bendahl, Mårten Fernö
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Prognostic factors in breast cancer are often measured on a continuous scale, but categorized for clinical decision-making. The primary aim of this study was to evaluate if accounting for continuous non-linear effects of the three
Externí odkaz:
https://doaj.org/article/3166cbdac85d45b787b1987b6afb105e
Autor:
Sara Jansson, Pär-Ola Bendahl, Dorthe Aamand Grabau, Anna-Karin Falck, Mårten Fernö, Kristina Aaltonen, Lisa Rydén
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e102176 (2014)
BackgroundTriple-negative breast cancer (TNBC) is a heterogeneous subgroup of breast cancer with poor prognosis and no targeted therapy available. Receptor tyrosine kinases (RTKs) are emerging targets in anticancer therapy and many RTK-inhibiting dru
Externí odkaz:
https://doaj.org/article/5e62c022483b4633ba2ff2e91cdc4372
Autor:
Charlotte Jørgensen, Carina Forsare, Anna Karin Falck, Kristina Lövgren, Mårten Fernö, Pär-Ola Bendahl, Kristina Aaltonen, Lisa Rydén
Publikováno v:
Breast Cancer Research and Treatment
Purpose The study aimed to investigate expression of epithelial-to-mesenchymal transition (EMT)-related proteins and phenotypes during breast cancer progression and to relate this to patient outcome. Methods Protein expression patterns of E-cadherin,
Autor:
Mårten Fernö, Dorthe Grabau, Carina Forsare, Olle Stål, Marie Sundqvist, Pär-Ola Bendahl, Lisa Rydén, Martin Bak, Per-Uno Malmström, Anna Karin Falck, Fredrika Killander
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Forsare, C, Bak, M, Falck, A K, Grabau, D, Killander, F, Malmström, P, Rydén, L, Stål, O, Sundqvist, M, Bendahl, P O & Fernö, M 2018, ' Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer ', BMC Cancer, vol. 18, 1226 . https://doi.org/10.1186/s12885-018-5123-x
BMC Cancer
Forsare, C, Bak, M, Falck, A K, Grabau, D, Killander, F, Malmström, P, Rydén, L, Stål, O, Sundqvist, M, Bendahl, P O & Fernö, M 2018, ' Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer ', BMC Cancer, vol. 18, 1226 . https://doi.org/10.1186/s12885-018-5123-x
BMC Cancer
BackgroundPrognostic factors in breast cancer are often measured on a continuous scale, but categorized for clinical decision-making. The primary aim of this study was to evaluate if accounting for continuous non-linear effects of the three factors a
Autor:
Forsare, Carina, Bak, Martin, Anna-Karin Falck, Grabau, Dorthe, Killander, Fredrika, Malmström, Per, Rydén, Lisa, Stål, Olle, Sundqvist, Marie, Pär-Ola Bendahl, Fernö, Mårten
Table S1. Patient and tumor characteristics for the different patient materials in the derivation set. (PDF 78 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a38689d57aa53f0ff42f6a36dfe6db0
Autor:
Forsare, Carina, Bak, Martin, Anna-Karin Falck, Grabau, Dorthe, Killander, Fredrika, Malmström, Per, Rydén, Lisa, Stål, Olle, Sundqvist, Marie, Pär-Ola Bendahl, Fernö, Mårten
Table S2. Categorized predictors in three or four groups. (PDF 66 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b9396ecaa5931ebc1119eef40147e10
Autor:
Pär-Ola Bendahl, Maria Karlsson, Kristina Aaltonen, Anna Karin Falck, Sara Jansson, Lisa Rydén, Kristian Pietras
Publikováno v:
Breast Cancer Research and Treatment
Purpose The platelet-derived growth factor (PDGF) signalling pathway is often dysregulated in cancer and PDGF-receptor expression has been linked to unfavourable prognostic factors in breast cancer (e.g. ER negativity, high Ki67 and high grade). This
Autor:
Lisa Rydén, Anna-Karin Falck, Carina Forsare, Olle Stål, Anna Ehinger, Per-Uno Malmström, Pär-Ola Bendahl, Dorthe Grabau, Mårten Fernö, C.W. Elston
Publikováno v:
Cancer Research. 75:P6-08
Objective: According to St Gallen recommendations from 2013, estrogen receptor (ER), progesterone receptor (PR), HER-2, and Ki-67 defines two subtypes of ER-positive and HER-2 normal breast cancer (BC): Luminal A-like and Luminal B-like. Patients wit
Autor:
Carina Forsare, Mårten Fernö, Lisa Rydén, Anna Ehinger, Pär-Ola Bendahl, Anna Karin Falck, Olle Stål, Dorthe Grabau, Per-Uno Malmström, C.W. Elston
Publikováno v:
Acta Oncologica; 56(1), pp 68-74 (2017)
Background: The St Gallen surrogate definition of the intrinsic subtypes of breast cancer consist of five subgroups based on estrogen receptor (ER), progesterone receptor (PgR), human epidermal growth factor receptor type 2 (HER2), and Ki-67. PgR and
Autor:
Mårten Fernö, Gunilla Chebil, Hans Olsson, Anna-Karin Falck, Pär-Ola Bendahl, Lisa Rydén, Andrada Röme
Publikováno v:
The British Journal of Surgery
Background Diagnosis by screening mammography is considered an independent positive prognostic factor, although the data are not fully in agreement. The aim of the study was to explore whether the mode of detection (screening‐detected versus sympto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8978a3bdcf6f3c1cf5c6b17bd21ef4e
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-127415
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-127415